Cardiovascular Journal of Africa: Vol 33 No 3 (MAY/JUNE 2022)

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 33, No 3, May/June 2022 152 AFRICA 29(2): 100–109. 28. Knutson S, Kelleman MS, Kochilas L. Implementation of developmental screening guidelines for children with congenital heart disease. J Pediatr 2016; 176: 135–141. 29. Black MM, Walker SP, Fernald LCH, Andersen CT, DiGirolamo AM, Lu C, et al. Early childhood development coming of age: science through the life course. Lancet 2017; 389(10064): 77–90. 30. Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B. Developmental potential in the first 5 years for children in developing countries. Lancet 2007; 369(9555): 60–70. 31. Wernovsky G, Donofrio MT, Jones MB, Sanz J. The neurodevelopmental consequences of congenital heart disease. Congenit Cardiol Today 2018; 16(6): 1–7. 32. Zühlke L. Reflections from the outgoing president. The future of cardiovascular disease in South Africa and the role of the South African Heart Association. SA Heart J 2018; 15(3): 174–177. 33. Zühlke L. Challenges and opportunities in paediatric cardiac services : Time for action. SA Heart J 2013; 10(2): 431–433. 34. Hoosen EGM, Cilliers AM, Hugo-Hamman CT, Brown SC, Harrisberg JR, Takawira FF, et al. Audit of paediatric cardiac services in South Africa. SA Heart J 2010; 7(1): 4–9. 35. Hoosen D, Hugo-Hamman C, Brown S, Harrisberg J, Takawira F, Govendrageloo K, et al. Optimal paediatric cardiac services in South Africa – what do we need? SA Heart J 2010; 7(1): 10–16. 36. Rappaport L. Neurodevelopmental outcome in children with congenital heart disease: a work in progress. Pediatrics 2015; 135(5): 926–927. 37. Visootsak J, Mahle WT, Kirshbom P, Huddleston L, Caron- M, Ransom A, et al. Neurodevelopmental outcomes in children with Down. Am J Med Genet 2011; 155(11): 2688–2691. 38. Visootsak J, Huddleston L, Buterbaugh A, Perkins A, Sherman S, Hunter J. Influence of CHDs on psycho-social and neurodevelopmental outcomes in children with Down syndrome. Cardiol Young 2016; 26(2): 250–256. 39. Smith R. Neurodevelopment, quality of life and burden of care of young children who have undergone cardiac interventions in central South Africa: threemonth and six-month post cardiac intervention outcomes. 2017. Available from: http://wiredspace.wits.ac.za/handle/10539/24873 40. Bayley N. Bayley Scales of Infant and Toddler Development. 3rd edn. Technical manual. Pearson Inc, 2006. 41. Soto CB, Olude O, Hoffmann RG, Bear L, Chin A, Dasgupta M, et al. Implementation of a routine developmental follow-up program for children with congenital heart disease: Early results. Congenit Heart Dis 2011; 6(5): 451–460. 42. Zemel BS, Pipan M, Stallings VA, Hall W, Schadt K. Growth charts for children with Down Syndrome in the United States. Pediatrics 2015; 136(5): e1204–1211. 43. World Health Organisation. WHO Child Growth Standards. Length/heightfor-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age. Methods and development. Department of Nutrition for Health and Development, 2006. Available from: http://www.who.int/ childgrowth/standards/Technical_report.pdf 44. Yildiz A, Celebioglu A, Olgun H. Distress levels in Turkish parents of children with congenital heart disease. Aust J Adv Nurs 2009; 26(3): 39–47. 45. Mussatto K. Adaptation of the child and family to life with a chronic illness. Cardiol Young 2006; 16(Suppl 3): 110–116. 46. Lantos GP. Consumer behaviour in action. Real life applications for marketing managers. New York: Routlege, 2015. 47. Abdin R. Parenting stress index short form. In: Parenting Stress Index Professional Manual. 3rd edn, 1995. 48. Daly JM, Levy BT, Xu Y, Levy SM, Fontana M. Recruitment strategies at the Iowa site for parent/infant pairs in a longitudinal dental caries study. Clin Trials 2016; 13(3): 311–318 49. Pike NA, Pemberton V, Allen K, Jacobs JP, Hsu DT, Lewis AB, et al. Challenges and successes of recruitment in the angiotensin-converting enzyme inhibition in infants with single ventricle trial of the Pediatric Heart Network. Cardiol Young 2013; 32(2): 248–257. 50. Burns KM, Pemberton VL, Pearson GD. The pediatric heart network: Meeting the challenges to multicenter studies in pediatric heart disease. Curr Opin Pediatr 2015; 27(5): 548–554. 51. Dittrich H, Bührer C, Grimmer I, Dittrich S, Abdul-Khaliq H, Lange PE. Neurodevelopment at 1 year of age in infants with congenital heart disease. Heart 2003; 89: 436–441. 52. Long SH, Eldridge BJ, Harris SR, Cheung MMH. Challenges in trying to implement an early intervention program for infants with congenital heart disease. Pediatr Phys Ther 2015; 27(1): 38–43. 53. Bayley N. Bayley Scales of Infant and Toddler Development. 3rd edn Administration manual. Pearson Inc, 2006. 54. Wei H, Roscigno CI, Swanson KM, Black BP, Hudson-barr D, Hanson CC. Parents ’ experiences of having a child undergoing congenital heart surgery : An emotional rollercoaster from shocking to blessing. Heart Lung J Acute Crit Care 2016; 45(2): 154–160. 55. Harvey KA, Kovalesky A, Woods RK, Loan LA. Experiences of mothers of infants with congenital heart disease before, during, and after complex cardiac surgery. Heart Lung J Acute Crit Care 2013; 42(6): 399–406. 56. Long SH, Harris SR, Eldridge BJ, Galea MP. Gross motor development is delayed following early cardiac surgery Suz. Cardiol Young 2012; 22(5): 574–582. 57. Bekele A, Janakiraman B. Physical therapy guideline for children with malnutrition in low income countries: clinical commentary. J Exerc Rehabil 2016; 12(4): 266–275. 58. Cloete J. Management of severe acute malnutrition. S Afr Med J 2015; 105(7): 605. 59. Facts About Developmental Disabilities. Center for Disease Control and Prevention. Available from: https://www.cdc.gov/ncbddd/developmentaldisabilities/facts.html 60. Brosig C, Butcher J, Butler S, Ilardi DL, Sanz JH, Struemph K, et al. Monitoring developmental risk and promoting success for children with congenital heart disease : recommendations for cardiac neurodevelopmental follow-up programs. Clin Pract Pediatr Psychol 2014; 2(2): 153–165. 61. Gessler P, Schmitt B, Prètre R, Latal B. Inflammatory response and neurodevelopmental outcome after open-heart surgery in children. Pediatr Cardiol 2009; 30(3): 301–305. 62. Visootsak J, Hess B, Bakeman R, Adamson LB. Effect of congenital heart defects on language development in toddlers with Down syndrome. J Intellect Disabil Res 2013; 57: 887–892. 63. Rollins CK, Newburger JW. Neurodevelopmental outcomes in congenital heart disease. Circulation 2014; 130: e124–126. 64. Sarrechia I, Miatton M, François K, Gewillig M, Meyns B, Vingerhoets G, et al. Neurodevelopmental outcome after surgery for acyanotic congenital heart disease. Res Dev Disabil 2015; 45–46: 58–68. 65. Mussatto KA, Hoffmann R, Hoffman G, Tweddell JS, Bear L, Cao Y, et al. Risk factors for abnormal developmental trajectories in young children with congenital heart disease. Circulation 2015; 132: 755–762. 66. Ravishankar C, Zak V, Williams IA, Bellinger DC, Gaynor JW, Ghanayem NS, et al. Association of Impaired linear growth and worse neurodevelopmental outcome in infants with single ventricle physiology: a report from the Pediatric Heart Network Infant Single Ventricle trial. J Pediatr 2014; 162(2): 250–256. 67. Noeder MM, Logan BA, Struemph KL, Condon N, Mueller I, Sands B, et al. Developmental screening in children with CHD: ages and stages questionnaires. Cardiol Young 2017; 27(8): 1447–1454.

RkJQdWJsaXNoZXIy NDIzNzc=